Correlation Between Agios Pharm and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Puma Biotechnology, you can compare the effects of market volatilities on Agios Pharm and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Puma Biotechnology.
Diversification Opportunities for Agios Pharm and Puma Biotechnology
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Agios and Puma is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Agios Pharm i.e., Agios Pharm and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Agios Pharm and Puma Biotechnology
Given the investment horizon of 90 days Agios Pharm is expected to generate 0.56 times more return on investment than Puma Biotechnology. However, Agios Pharm is 1.79 times less risky than Puma Biotechnology. It trades about 0.27 of its potential returns per unit of risk. Puma Biotechnology is currently generating about 0.08 per unit of risk. If you would invest 4,508 in Agios Pharm on August 25, 2024 and sell it today you would earn a total of 1,060 from holding Agios Pharm or generate 23.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agios Pharm vs. Puma Biotechnology
Performance |
| Timeline |
| Agios Pharm |
| Puma Biotechnology |
Agios Pharm and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agios Pharm and Puma Biotechnology
The main advantage of trading using opposite Agios Pharm and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |